MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$592.57
−0.14%Aug 26, 2026, 17:21 UTC
Medpace reported second-quarter earnings that beat expectations.
Source:Aug 22, 2026, 07:07 UTC
Allworth Financial LP acquired a new stake in Medpace Holdings, Inc. during the second quarter of 2026, purchasing 3,894 shares valued at approximately $2,062,000, as disclosed in a 13F filing.
Source:Aug 20, 2026, 07:13 UTC
Abacus FCF Advisors LLC acquired a new stake in Medpace Holdings, Inc. during the second quarter, purchasing 12,529 shares valued at approximately $6.63 million.
Source:Aug 14, 2026, 03:58 UTC
Medpace Holdings raised its 2026 revenue guidance to a midpoint of $2.85 billion during its second-quarter earnings call.
Source:Aug 10, 2026, 12:23 UTC
Kuehn Law, PLLC announced an investigation into potential breaches of fiduciary duty by officers and directors of Medpace Holdings, Inc., related to a federal securities lawsuit alleging misrepresentation of backlog cancellation rates and business conditions.
Source:Aug 5, 2026, 15:36 UTC
Medpace Holdings reported record bookings and a higher book-to-bill ratio in the second quarter of 2026, reversing the weaker first-quarter trend.
Source:Jul 22, 2026, 20:15 UTC
Medpace Holdings, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting revenue of $707.3 million, a 17.2% increase from the prior-year period.
Jun 4, 2026, 00:00 UTC
Medpace Holdings, Inc. appointed Brad W. Hansman as Executive Vice President, Operations effective June 1, 2026.
Jun 1, 2026, 07:51 UTC
A class action lawsuit was filed against Medpace Holdings, Inc. for securities law violations.